139
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Safety Evaluation of Nanoliposomes Containing Cyclosporine A After Ocular Administration

, , , , &
Pages 453-456 | Received 31 Oct 2011, Accepted 18 Jan 2012, Published online: 11 May 2012

REFERENCES

  • Hunter PA, Garner A, Wilhelmus KR, Rice NS, Jones BR. Corneal graft rejection: a new rabbit model and cyclosporin-A. Br J Ophthalmol. 1982;66:292–302.
  • Lam H, Dana MR. Corneal graft rejection. Int Ophthalmol Clin. 2009;49:31–41.
  • Theng JT, Ti SE, Zhou L et al. Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes. Invest Ophthalmol Vis Sci. 2003;44:4895–4899.
  • Malaekeh-Nikouei B, Jaafari MR, Tabassi SA, Samiei A. The enhancement of immunosuppressive effects of cyclosporine A on human T-cells using fusogenic liposomes. Colloids Surf B Biointerfaces. 2008;67:238–244.
  • Ahlers C, Kreideweiss S, Nordheim A, Rühlmann A. Cyclosporin A inhibits Ca2+-mediated upregulation of the DNA repair enzyme DNA polymerase beta in human peripheral blood mononuclear cells. Eur J Biochem. 1999;264:952–959.
  • Fua H, Larkina DFP, George AJT. Immune modulation in corneal transplantation. Transplant Rev. 2008;22:105–115.
  • Wiederholt M, Kössendrup D, Schulz W, Hoffmann F. Pharmacokinetic of topical cyclosporin A in the rabbit eye. Invest Ophthalmol Vis Sci. 1986;27:519–524.
  • Kiang E, Tesavibul N, Yee R, Kellaway J, Przepiorka D. The use of topical cyclosporin A in ocular graft-versus-host-disease. Bone Marrow Transplant. 1998;22:147–151.
  • Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145–160.
  • Benita S. Prevention of topical and ocular oxidative stress by positively charged submicron emulsion. Biomed Pharmacother. 1999;53:193–206.
  • Robert PY, Leconte V, Olivé C, Ratsimbazafy V, Javerliat M, Adenis JP. Cyclosporin A eyedrops: manufacturing, toxicity, pharmacokinetics and indications in 2000. J Fr Optalmol. 2001;24:527–535.
  • Heydenreich AV, Westmeier R, Pedersen N, Poulsen HS, Kristensen HG. Preparation and purification of cationic solid lipid nanospheres–effects on particle size, physical stability and cell toxicity. Int J Pharm. 2003;254:83–87.
  • Filion MC, Phillips NC. Major limitations in the use of cationic liposomes for DNA delivery. Int J Pharm. 1998;162:159–170.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.